Company Profile LogoOptherion

Optherion, Inc., a biotechnology company, develops diagnostic and disease-modifying therapeutics for the management and treatment of

Edit IconSuggest an Edit
Medical
Health Care
Biotechnology

    Unlock insights on Optherion and 2M+ companies now!

    About Optherion

    Optherion, Inc., a biotechnology company, develops diagnostic and disease-modifying therapeutics for the management and treatment of early-stage age-related macular degeneration, dense deposit disease, atypical hemolytic uremic syndrome, and other chronic diseases involving the alternative complement cascade. The company was founded in 2005 and is based in New Haven, Connecticut.

    Company Highlights
    Year Founded

    2005

    icon-altEmployees

    2

    Location (HQ)

    USA

    Since Last Funding

    14 years 12 months

    Monthly Website Visitors

    475

    icon-altTotal Investment Amt

    $42M

    Last Funding Round

    Debt Financing

    Key Metrics

    Senior Hires

    NameLinkedin ProfilePositionDate Joined
    John Doehttps://www.linkedin.com/in/johndoeCEOCEO
    Jane Doehttps://www.linkedin.com/in/janedoeCTOCTO
    John Smithhttps://www.linkedin.com/in/johnsmithCFOCFO
    Jane Smithhttps://www.linkedin.com/in/janesmithCOOCOO
    Get API access to complete private company database with growth metrics from 15 sources

    Similar Companies

    Medical

    Health Care

    Biotechnology

    Biotechnology Research